UPDATE: JPMorgan Downgrades LivePerson (LPSN) to Neutral

Northland Capital Markets Downgrades LivePerson (LPSN) to Market Perform

Northland Capital Markets analyst Michael Latimore downgraded LivePerson (NASDAQ: LPSN) from Outperform to Market Perform.

The analyst commented, "Solid 4Q, with a substantial EBITDA beat. LPSN abruptly announced stopping its plan to get to 200 sales reps; this follows the abrupt decision to... More

Needham & Company Downgrades LivePerson (LPSN) to Hold

Needham & Company analyst Ryan MacDonald downgraded LivePerson (NASDAQ: LPSN) from Buy to Hold.

The analyst commented, "We are downgrading LivePerson to a Hold rating following the company's 4Q21 results in which growth headwinds related to the company's gainshare and Bella Health offerings... More

LivePerson (LPSN) PT Lowered to $20 at Mizuho Securities

Mizuho Securities analyst Siti Panigrahi lowered the price target on LivePerson (NASDAQ: LPSN) to $20.00 (from $32.00) while maintaining a Neutral rating.

The analyst commented, "LivePerson posted solid Q4 results but guided to FY22 growth well below consensus (18% Y/Y at midpoint vs. 27%... More

B.Riley Downgrades LivePerson (LPSN) to Neutral

B.Riley analyst Zachary Cummings downgraded LivePerson (NASDAQ: LPSN) from Buy to Neutral with a price target of $23.00 (from $47.00).

For an analyst ratings summary and ratings history on LivePerson click here. For more ratings news on LivePerson click here.

Shares of LivePerson closed at $24.34 yesterday.

UPDATE: KeyBanc Downgrades LivePerson (LPSN) to Sector Weight

(Updated - February 25, 2022 5:43 AM EST)

KeyBanc analyst Steve Enders downgraded LivePerson (NASDAQ: LPSN) from Overweight to Sector Weight.

The analyst comments "LPSN reported in-line revenue and $15M in EBITDA upside following a strategy shift toward a more prudent growth/spend profile... More

UPDATE: Evercore ISI Downgrades LivePerson (LPSN) to In Line

(Updated - February 25, 2022 3:14 AM EST)

Evercore ISI analyst Peter Levine downgraded LivePerson (NASDAQ: LPSN) from Outperform to In Line with a price target of $20.00 (from $75.00).

The analyst comments "While we remain bullish on the broader UC/customer engagement market, we are downgrading LPSN to In Line after reporting sub-par results and a weak outlook (~10% guide down from its initial outlook). We believe that there are simply better assets to own for those looking to get exposure to this market. Given the companys inconsistent execution and an unclear... More

LivePerson (LPSN) Misses Q4 EPS by 24c

LivePerson (NASDAQ: LPSN) reported Q4 EPS of ($0.70), $0.24 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $123.8 million versus the consensus estimate of $123.88 million.

GUIDANCE:

LivePerson sees FY2022 revenue of $544.8-563.3 million, versus the consensus of $598... More